| Health / Medical Topics |
Glembatumumab
A human monoclonal antibody against transmembrane glycoprotein non-metastatic melanoma protein B (GPNMB). Glembatumumab binds to GPNMB on cancer cells, but alone does not appear to inhibit cancer cell growth. However, this antibody could be utilized to deliver a conjugated cytotoxic agent to GPNMB-expressing tumor cells. GPNMB, overexpressed on the surface of various cancer cells, plays a key role in cancer cell proliferation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat different types of leukemia and other cancers of the blood, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma…
The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a…
A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10…
A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.
A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal…
A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial…
